Articles for AstraZeneca (LSE: AZN)

Why I’d sell this FTSE 250 flop and buy AstraZeneca plc instead

G A Chester sees a much stronger investment case for AstraZeneca plc (LON:AZN) than this FTSE 250 (INDEXFTSE:MCX) stock. More »

Is AstraZeneca plc a strong buy after Q3 results?

Is AstraZeneca plc (LON: AZN) still on course for a recovery? More »

Why I’d buy AstraZeneca plc over this soaring growth stock

Harvey Jones says AstraZeneca plc (LON: AZN) could hit new peaks and put this biotechnology upstart in its place. More »

This FTSE 100 growth stock could be a better buy than AstraZeneca plc

AstraZeneca plc (LON: AZN) is a popular healthcare stock among UK investors. But is this FTSE 100 (INDEXFTSE:UKX) joint replacement specialist a better buy?... More »

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player. More »

Why I see more upside ahead for AstraZeneca plc

I believe that AstraZeneca plc's (LON: AZN) growth is only just getting started and there's still plenty of potential for investors. More »

Why I’d buy AstraZeneca plc for fat dividends and pipeline potential

The expiry of blockbuster patents has led some to doubt AstraZeneca plc (LON: AZN), but one Fool believes the company can innovate its way... More »

One growth stock I’d buy ahead of Astrazeneca plc

If dividends aren't a priority, Paul Summers think this top growth stock might be a better bet than Astrazeneca plc (LON:AZN). More »

AstraZeneca plc isn’t the only pharma star that could make you rich

AstraZeneca plc (LON: AZN) isn't the only pharma giant that could make you rich. Here Royston Wild looks at another drugs star with brilliant... More »

Why I’d ditch this defensive dividend stock to buy AstraZeneca plc

G A Chester argues AstraZeneca plc (LON:AZN) is the pick of two defensive dividend stocks. More »

This small-cap stock could be a better dividend buy than AstraZeneca plc

Dividend investing: should you buy AstraZeneca plc (LON:AZN) after a setback in its ‘Mystic’ clinical trial, or consider this small-cap instead? More »

Why AstraZeneca plc could have a major impact on your investment performance

AstraZeneca plc (LON: AZN) could be about to deliver vastly-improved financial performance. More »

One super dividend stock I’d buy along with AstraZeneca plc

This firm’s impressive finances make it a serious potential pairing in my portfolio with AstraZeneca plc (LON: AZN). More »

Why this dividend growth stock could be a better buy than AstraZeneca plc

Roland Head explains why he's not buying AstraZeneca plc (LON:AZN) today. More »

Why I’m not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their dividends

Edward Sheldon looks at drugs giant AstraZeneca plc (LON: AZN) and banking behemoth Barclays plc (LON: BARC) and explains why he won't be investing... More »

Top stocks for August

We asked our analysts to share their top stock picks for the coming month. More »

AstraZeneca plc’s shock plunge is a buying opportunity for the brave

This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones. More »

Is AstraZeneca plc a falling knife to catch after dropping 15% today?

AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now. More »

Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

AstraZeneca plc (LSE: AZN) looks attractive to me today. More »

2 FTSE 100 stocks for retirement income AND growth

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver above-average income and strong capital growth. More »